GSK signs agreement with U.S. government to lower drug prices and expand access for Americans
LONDON – GSK plc (LSE/NYSE: GSK) announced that it has entered into an agreement with the U.S. Administration to lower the cost of prescription medicines for American patients, including GSK’s broad respiratory portfolio which is used to treat the more…